By Jamie Minchin, Senior Associate, Vaccine Acceptance and Demand and Meaghan Charlton, Senior Manager, Vaccine Acceptance

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

Skoll Foundation Funds Sabin Vaccine Institute, Dalberg and JSI Research & Training Institute, Inc. to Establish COVID-19 Vaccine Equity Project

As COVID-19 vaccine developers generate clinical evidence of safety and effectiveness needed for vaccine approval, this project will help prepare for the efficient and equitable distribution of vaccines globally by ensuring that national immunization programs have the resources and health systems in place to achieve sustainable global protection from COVID-19 by 2022 and strengthen capacity for vaccination across the life span.

On September 8, 2020, Bruce Gellin, MD, MPH, president of Global Immunization at the Sabin Vaccine Institute (Sabin), participated in a panel titled, “The Science of Vaccine Confidence,” as part of the 2020 Virtual National Health Research Forum hosted by

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and public health in the midst of the COVID-19 pandemic.

This blog post is part of Sabin’s Pivoting in a Pandemic series, which captures stories of extraordinary leaders who are adapting to advance research and protecting public health in the midst of COVID-19.

On Dr. Albert B. Sabin’s birthday, his legacy is a reminder that vaccination and health equity go hand-in-hand.

Most vaccination programs focus on protecting children, even though the major burden of vaccine-preventable diseases is in adults.

Pages

Subscribe to RSS - Access & Uptake